USA Ketorolac Tromethamine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Ketorolac Tromethamine market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Ketorolac Tromethamine market. Detailed analysis of key players, along with key growth strategies adopted by Ketorolac Tromethamine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Akorn

    • Amphastar Pharmaceuticals

    • Sagent Pharmaceuticals

    • Omeros Corporation

    • West Ward Pharmaceuticals

    • Aurobindo Pharma

    • Fresenius Kabi

    • Teva

    • Sandoz

    • Gland Pharma Limited

    • Sun Pharmaceutical

    • Pfizer

    • Allergan

    • Mylan

    • Apotex

    By Type:

    • Injection

    • Ophthalmic

    • Nasal

    • Oral tablet

    By End-User:

    • Short-term treatment of pain

    • Ophthalmic Surgery

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Ketorolac Tromethamine Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Ketorolac Tromethamine Market Size and Growth Rate of Injection from 2016 to 2027

      • 1.3.2 USA Ketorolac Tromethamine Market Size and Growth Rate of Ophthalmic from 2016 to 2027

      • 1.3.3 USA Ketorolac Tromethamine Market Size and Growth Rate of Nasal from 2016 to 2027

      • 1.3.4 USA Ketorolac Tromethamine Market Size and Growth Rate of Oral tablet from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Ketorolac Tromethamine Market Size and Growth Rate of Short-term treatment of pain from 2016 to 2027

      • 1.4.2 USA Ketorolac Tromethamine Market Size and Growth Rate of Ophthalmic Surgery from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Ketorolac Tromethamine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Ketorolac Tromethamine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Ketorolac Tromethamine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Ketorolac Tromethamine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Ketorolac Tromethamine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Ketorolac Tromethamine by Major Types

      • 3.4.1 Market Size and Growth Rate of Injection

      • 3.4.2 Market Size and Growth Rate of Ophthalmic

      • 3.4.3 Market Size and Growth Rate of Nasal

      • 3.4.4 Market Size and Growth Rate of Oral tablet

    4 Segmentation of Ketorolac Tromethamine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Ketorolac Tromethamine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Ketorolac Tromethamine in Short-term treatment of pain

      • 4.4.2 Market Size and Growth Rate of Ketorolac Tromethamine in Ophthalmic Surgery

    5 Market Analysis by Regions

    • 5.1 USA Ketorolac Tromethamine Production Analysis by Regions

    • 5.2 USA Ketorolac Tromethamine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Ketorolac Tromethamine Landscape Analysis

    • 6.1 West USA Ketorolac Tromethamine Landscape Analysis by Major Types

    • 6.2 West USA Ketorolac Tromethamine Landscape Analysis by Major End-Users

    7 South USA Ketorolac Tromethamine Landscape Analysis

    • 7.1 South USA Ketorolac Tromethamine Landscape Analysis by Major Types

    • 7.2 South USA Ketorolac Tromethamine Landscape Analysis by Major End-Users

    8 Middle West USA Ketorolac Tromethamine Landscape Analysis

    • 8.1 Middle West USA Ketorolac Tromethamine Landscape Analysis by Major Types

    • 8.2 Middle West USA Ketorolac Tromethamine Landscape Analysis by Major End-Users

    9 Northeast USA Ketorolac Tromethamine Landscape Analysis

    • 9.1 Northeast USA Ketorolac Tromethamine Landscape Analysis by Major Types

    • 9.2 Northeast USA Ketorolac Tromethamine Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Akorn

        • 10.1.1 Akorn Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Amphastar Pharmaceuticals

        • 10.2.1 Amphastar Pharmaceuticals Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Sagent Pharmaceuticals

        • 10.3.1 Sagent Pharmaceuticals Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Omeros Corporation

        • 10.4.1 Omeros Corporation Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 West Ward Pharmaceuticals

        • 10.5.1 West Ward Pharmaceuticals Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Aurobindo Pharma

        • 10.6.1 Aurobindo Pharma Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Fresenius Kabi

        • 10.7.1 Fresenius Kabi Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Teva

        • 10.8.1 Teva Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Sandoz

        • 10.9.1 Sandoz Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Gland Pharma Limited

        • 10.10.1 Gland Pharma Limited Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Sun Pharmaceutical

        • 10.11.1 Sun Pharmaceutical Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Pfizer

        • 10.12.1 Pfizer Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Allergan

        • 10.13.1 Allergan Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Mylan

        • 10.14.1 Mylan Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Apotex

        • 10.15.1 Apotex Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Ketorolac Tromethamine Market Size and Growth Rate of Injection from 2016 to 2027

    • Figure USA Ketorolac Tromethamine Market Size and Growth Rate of Ophthalmic from 2016 to 2027

    • Figure USA Ketorolac Tromethamine Market Size and Growth Rate of Nasal from 2016 to 2027

    • Figure USA Ketorolac Tromethamine Market Size and Growth Rate of Oral tablet from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Ketorolac Tromethamine Market Size and Growth Rate of Short-term treatment of pain from 2016 to 2027

    • Figure USA Ketorolac Tromethamine Market Size and Growth Rate of Ophthalmic Surgery from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Ketorolac Tromethamine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Ketorolac Tromethamine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Ketorolac Tromethamine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Ketorolac Tromethamine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Ketorolac Tromethamine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Ketorolac Tromethamine

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Ketorolac Tromethamine by Different Types from 2016 to 2027

    • Table Consumption Share of Ketorolac Tromethamine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Injection

    • Figure Market Size and Growth Rate of Ophthalmic

    • Figure Market Size and Growth Rate of Nasal

    • Figure Market Size and Growth Rate of Oral tablet

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Ketorolac Tromethamine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Ketorolac Tromethamine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Short-term treatment of pain

    • Figure Market Size and Growth Rate of Ophthalmic Surgery

    • Table USA Ketorolac Tromethamine Production by Regions

    • Table USA Ketorolac Tromethamine Production Share by Regions

    • Figure USA Ketorolac Tromethamine Production Share by Regions in 2016

    • Figure USA Ketorolac Tromethamine Production Share by Regions in 2021

    • Figure USA Ketorolac Tromethamine Production Share by Regions in 2027

    • Table USA Ketorolac Tromethamine Consumption by Regions

    • Table USA Ketorolac Tromethamine Consumption Share by Regions

    • Figure USA Ketorolac Tromethamine Consumption Share by Regions in 2016

    • Figure USA Ketorolac Tromethamine Consumption Share by Regions in 2021

    • Figure USA Ketorolac Tromethamine Consumption Share by Regions in 2027

    • Table West USA Ketorolac Tromethamine Consumption by Types from 2016 to 2027

    • Table West USA Ketorolac Tromethamine Consumption Share by Types from 2016 to 2027

    • Figure West USA Ketorolac Tromethamine Consumption Share by Types in 2016

    • Figure West USA Ketorolac Tromethamine Consumption Share by Types in 2021

    • Figure West USA Ketorolac Tromethamine Consumption Share by Types in 2027

    • Table West USA Ketorolac Tromethamine Consumption by End-Users from 2016 to 2027

    • Table West USA Ketorolac Tromethamine Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Ketorolac Tromethamine Consumption Share by End-Users in 2016

    • Figure West USA Ketorolac Tromethamine Consumption Share by End-Users in 2021

    • Figure West USA Ketorolac Tromethamine Consumption Share by End-Users in 2027

    • Table South USA Ketorolac Tromethamine Consumption by Types from 2016 to 2027

    • Table South USA Ketorolac Tromethamine Consumption Share by Types from 2016 to 2027

    • Figure South USA Ketorolac Tromethamine Consumption Share by Types in 2016

    • Figure South USA Ketorolac Tromethamine Consumption Share by Types in 2021

    • Figure South USA Ketorolac Tromethamine Consumption Share by Types in 2027

    • Table South USA Ketorolac Tromethamine Consumption by End-Users from 2016 to 2027

    • Table South USA Ketorolac Tromethamine Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Ketorolac Tromethamine Consumption Share by End-Users in 2016

    • Figure South USA Ketorolac Tromethamine Consumption Share by End-Users in 2021

    • Figure South USA Ketorolac Tromethamine Consumption Share by End-Users in 2027

    • Table Middle West USA Ketorolac Tromethamine Consumption by Types from 2016 to 2027

    • Table Middle West USA Ketorolac Tromethamine Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Ketorolac Tromethamine Consumption Share by Types in 2016

    • Figure Middle West USA Ketorolac Tromethamine Consumption Share by Types in 2021

    • Figure Middle West USA Ketorolac Tromethamine Consumption Share by Types in 2027

    • Table Middle West USA Ketorolac Tromethamine Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Ketorolac Tromethamine Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Ketorolac Tromethamine Consumption Share by End-Users in 2016

    • Figure Middle West USA Ketorolac Tromethamine Consumption Share by End-Users in 2021

    • Figure Middle West USA Ketorolac Tromethamine Consumption Share by End-Users in 2027

    • Table Northeast USA Ketorolac Tromethamine Consumption by Types from 2016 to 2027

    • Table Northeast USA Ketorolac Tromethamine Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Ketorolac Tromethamine Consumption Share by Types in 2016

    • Figure Northeast USA Ketorolac Tromethamine Consumption Share by Types in 2021

    • Figure Northeast USA Ketorolac Tromethamine Consumption Share by Types in 2027

    • Table Northeast USA Ketorolac Tromethamine Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Ketorolac Tromethamine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Ketorolac Tromethamine Consumption Share by End-Users in 2016

    • Figure Northeast USA Ketorolac Tromethamine Consumption Share by End-Users in 2021

    • Figure Northeast USA Ketorolac Tromethamine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Akorn

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Akorn

    • Figure Sales and Growth Rate Analysis of Akorn

    • Figure Revenue and Market Share Analysis of Akorn

    • Table Product and Service Introduction of Akorn

    • Table Company Profile and Development Status of Amphastar Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amphastar Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Amphastar Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Amphastar Pharmaceuticals

    • Table Product and Service Introduction of Amphastar Pharmaceuticals

    • Table Company Profile and Development Status of Sagent Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sagent Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sagent Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sagent Pharmaceuticals

    • Table Product and Service Introduction of Sagent Pharmaceuticals

    • Table Company Profile and Development Status of Omeros Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omeros Corporation

    • Figure Sales and Growth Rate Analysis of Omeros Corporation

    • Figure Revenue and Market Share Analysis of Omeros Corporation

    • Table Product and Service Introduction of Omeros Corporation

    • Table Company Profile and Development Status of West Ward Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of West Ward Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of West Ward Pharmaceuticals

    • Figure Revenue and Market Share Analysis of West Ward Pharmaceuticals

    • Table Product and Service Introduction of West Ward Pharmaceuticals

    • Table Company Profile and Development Status of Aurobindo Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo Pharma

    • Figure Sales and Growth Rate Analysis of Aurobindo Pharma

    • Figure Revenue and Market Share Analysis of Aurobindo Pharma

    • Table Product and Service Introduction of Aurobindo Pharma

    • Table Company Profile and Development Status of Fresenius Kabi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Kabi

    • Figure Sales and Growth Rate Analysis of Fresenius Kabi

    • Figure Revenue and Market Share Analysis of Fresenius Kabi

    • Table Product and Service Introduction of Fresenius Kabi

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Sandoz

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz

    • Figure Sales and Growth Rate Analysis of Sandoz

    • Figure Revenue and Market Share Analysis of Sandoz

    • Table Product and Service Introduction of Sandoz

    • Table Company Profile and Development Status of Gland Pharma Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gland Pharma Limited

    • Figure Sales and Growth Rate Analysis of Gland Pharma Limited

    • Figure Revenue and Market Share Analysis of Gland Pharma Limited

    • Table Product and Service Introduction of Gland Pharma Limited

    • Table Company Profile and Development Status of Sun Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical

    • Table Product and Service Introduction of Sun Pharmaceutical

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Apotex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex

    • Figure Sales and Growth Rate Analysis of Apotex

    • Figure Revenue and Market Share Analysis of Apotex

    • Table Product and Service Introduction of Apotex


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.